Authors


Kim Thomas

Latest:

Connecting the Manufacturing Process to Patient Wellness

Manufacturers of biopharmaceuticals can improve productivity by taking patient wellness into account.


Amardeep Bhalla, PhD

Latest:

Disposable Bioreactors for Cells and Microbes

Productivities similar to those achieved with stirred tanks can be achieved with disposable bioreactors.


Carlos A. Dominguez

Latest:

Improving Tangential Flow Filtration Yield

Best methods to maximize product yield and membrane lifetime to enhance a tangential flow filtration process.



Millie Ullah, PhD

Latest:

Disposable Bioreactors for Cells and Microbes

Productivities similar to those achieved with stirred tanks can be achieved with disposable bioreactors.


Binh Q. Thai

Latest:

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.


Nathan Pease

Latest:

A Case Study of Developing Analytical Methods

Contract manufacturers must plan for increased analytical resources in development and quality control.



Brian Kelley

Latest:

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.


Genesio Murano

Latest:

Biologics: Can There Be Abbreviated Applications, Generics, or Follow-On Products?

In this question-and-answer discussion of "generic" biologics, the authors contend small changes in manufacturing of biologics dramatically affect the safety and efficacy of the therapeutic molecule.


Phenomenex

Latest:

Mastering SEC Biotherapeutic Characterization and Method Development

Webinar Date/Time: Tue, Jun 3, 2025 2:00 PM EDT


Guido Stroehlein, PhD

Latest:

Increasing Capacity Utilization in Protein A Chromatography

A twin-column periodic countercurrent capture process that combines an efficient sequential, countercurrent loading process with a minimal twin-column hardware configuration is described.




Mark DeLuca

Latest:

Final Word: Beware of Patent Infringement During Discovery Research

Experimenting with a rival?s patented compound may land you in hot water.



Pete Gagnon

Latest:

Purification of IgM Monoclonal Antibodies

Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.



Chris Donaldson

Latest:

Formulation Studies of an Adsorbed Conjugate Vaccine

NeisVac-C is a polysaccharide-protein conjugate vaccine for use against Neisseria meningitidis serogroup C infection. The Phase 1 clinical formulation consisted of physiological saline, thimerosal, and aluminum hydroxide. The long-term stability data for both the PBS and saline formulations are presented in this article.


William Downey

Latest:

Biopharma Contract Manufacturing Prices Go Up—and Down

A dynamic market, industry consolidation, and demand fluctuations lead to a mixed picture of pricing results.


Gregory S. Blank

Latest:

Purification Strategies to Process 5 g/L Titers of Monoclonal Antibodies

Altering the order of operations, using new resins, and increasing dynamic binding capacity can obviate the need for major facilty changes.


Justin McCue

Latest:

Modeling of Biopharmaceutical Processes. Part 2: Process Chromatography Unit Operation

A review of some recent contributions in process chromatography.


John Landis

Latest:

Biologics: Can There Be Abbreviated Applications, Generics, or Follow-On Products?

In this question-and-answer discussion of "generic" biologics, the authors contend small changes in manufacturing of biologics dramatically affect the safety and efficacy of the therapeutic molecule.


Frank Hensel

Latest:

Purification of IgM Monoclonal Antibodies

Manufacturing challenges surround the use of IgM monoclonal antibodies, but these can be overcome with current technology.



James M. Robinson

Latest:

Tanks for the Memories

Single-use systems have greatly improved and simplified common manufacturing issues.


Jeffrey A. Jung

Latest:

Royalty Interest Investing: Addressing the Out-License Assignability Issue

Several legal considerations are key to protect the buyer and seller in royalty interest transactions.


David Onions, PhD, FRSE

Latest:

Detection of Cache Valley Virus in Biologics Manufactured in CHO Cells

Avoid manufacturing failures by effective viral inactivation.


Peter N. Townshend

Latest:

Trends in Convertible Note Financing for Biotechs

As more biotechs turn to convertible note financing instead of traditional venture capital, they need to be aware of investors' demands.


Robert Garnick

Latest:

Biologics: Can There Be Abbreviated Applications, Generics, or Follow-On Products?

In this question-and-answer discussion of "generic" biologics, the authors contend small changes in manufacturing of biologics dramatically affect the safety and efficacy of the therapeutic molecule.

© 2025 MJH Life Sciences

All rights reserved.